Sanuwave Health Inc (SNWV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,937 | -10,430 | -11,631 | -5,538 | -6,439 |
| Depreciation Amortization | 1,496 | 71 | 2,940 | 565 | 584 |
| Accounts receivable | -2,582 | -9 | -23 | 251 | -413 |
| Accounts payable and accrued liabilities | 3,015 | -139 | 276 | 784 | 204 |
| Other Working Capital | 1,767 | 2,392 | 798 | 1,836 | -496 |
| Other Operating Activity | 14,523 | 1,703 | 4,019 | 573 | 3,361 |
| Operating Cash Flow | $-12,718 | $-6,411 | $-3,621 | $-1,529 | $-3,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -53 | -54 | -43 | N/A | -9 |
| Net Acquisitions | -20,000 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-20,053 | $-54 | $-43 | $N/A | $-9 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 14,447 | 1,305 | 3,518 | 1,754 | 206 |
| Debt Issued | 614 | N/A | N/A | N/A | 175 |
| Debt Repayment | -143 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 21,514 | 4,558 | 41 | 93 | 3,193 |
| Other Financing Activity | -2,985 | 1,997 | -241 | 270 | -366 |
| Financing Cash Flow | $33,447 | $7,860 | $3,318 | $2,117 | $3,208 |
| Exchange Rate Effect | 0 | 1 | -19 | 8 | -19 |
| Beginning Cash Position | 1,761 | 365 | 730 | 134 | 153 |
| End Cash Position | 2,437 | 1,761 | 365 | 730 | 134 |
| Net Cash Flow | $676 | $1,396 | $-366 | $597 | $-19 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,718 | -6,411 | -3,621 | -1,529 | -3,200 |
| Capital Expenditure | -53 | -54 | -43 | N/A | -10 |
| Free Cash Flow | -12,771 | -6,465 | -3,664 | -1,529 | -3,210 |